Galaxy Surfactants Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 12, 2025, 1:50 pm

Market Cap	7,421 Cr.
Current Price	2,090
High / Low	3,370/2,072
Stock P/E	24.2
Book Value	640
Dividend Yield	1.05 %
ROCE	17.4 %
ROE	14.9 %
Face Value	10.0
PEG Ratio	84.32

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Galaxy Surfactants Ltd

Competitors of Galaxy Surfactants Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujarat Natural Resources Ltd	300 Cr.	23.3	24.3/9.92		8.53	0.00 %	1.12 %	3.49 %	10.0
Dolphin Offshore Enterprises (India) Ltd	1,004 Cr.	259	949/200	27.2	60.6	0.00 %	0.97 %	3.22 %	1.00
Deep Energy Resources Ltd	999 Cr.	312	348/150	694	121	0.00 %	0.39 %	0.35 %	10.0
Selan Explorations Technology Ltd	803 Cr.	528	1,100/404	11.4	286	0.00 %	12.3 %	8.70 %	10.0
Oil India Ltd	59,404 Cr.	365	768/328	8.05	324	2.88 %	17.7 %	18.0 %	10.0
Industry Average	29,957.08 Cr	435.51		79.64	544.76	1.00%	10.49%	9.47%	6.85

All Competitor Stocks of Galaxy Surfactants Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	929	1,053	1,159	1,232	1,085	980	942	983	940	929	974	1,063	1,042
Expenses	853	908	1,011	1,100	931	845	819	858	828	827	850	935	936
Operating Profit	76	145	148	132	154	135	123	125	112	102	124	128	106
OPM %	8%	14%	13%	11%	14%	14%	13%	13%	12%	11%	13%	12%	10%
Other Income	2	1	-2	1	4	7	2	3	6	24	5	9	4
Interest	3	3	4	6	6	6	6	5	6	5	4	4	5
Depreciation	18	18	19	20	22	23	24	25	25	26	27	28	28
Profit before tax	58	124	123	107	131	113	96	98	88	94	99	104	77
Tax %	21%	21%	18%	21%	19%	20%	22%	21%	19%	18%	19%	19%	16%
Net Profit	46	98	100	84	106	91	75	77	71	78	80	85	65
EPS in Rs	12.87	27.75	28.31	23.66	29.96	25.53	21.20	21.84	20.13	21.86	22.48	23.89	18.22

Last Updated: February 28, 2025, 7:56 pm

Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹1,042.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,063.00 Cr. (Sep 2024) to ₹1,042.00 Cr., marking a decrease of 21.00 Cr..
For Expenses, as of Dec 2024, the value is ₹936.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 935.00 Cr. (Sep 2024) to ₹936.00 Cr., marking an increase of ₹1.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Sep 2024) to ₹106.00 Cr., marking a decrease of 22.00 Cr..
For OPM %, as of Dec 2024, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Sep 2024) to 10.00%, marking a decrease of 2.00%.
For Other Income, as of Dec 2024, the value is ₹4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to ₹4.00 Cr., marking a decrease of 5.00 Cr..
For Interest, as of Dec 2024, the value is ₹5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Sep 2024) to ₹5.00 Cr., marking an increase of ₹1.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹28.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 28.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 104.00 Cr. (Sep 2024) to ₹77.00 Cr., marking a decrease of 27.00 Cr..
For Tax %, as of Dec 2024, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 19.00% (Sep 2024) to 16.00%, marking a decrease of 3.00%.
For Net Profit, as of Dec 2024, the value is ₹65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 85.00 Cr. (Sep 2024) to ₹65.00 Cr., marking a decrease of 20.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 18.22. The value appears to be declining and may need further review. It has decreased from ₹23.89 (Sep 2024) to 18.22, marking a decrease of ₹5.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:17 pm

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,870	1,799	2,158	2,432	2,761	2,595	2,782	3,684	4,462	3,792	4,008
Expenses	1,681	1,563	1,886	2,144	2,408	2,226	2,334	3,284	3,894	3,330	3,549
Operating Profit	190	236	271	288	353	369	449	401	568	462	459
OPM %	10%	13%	13%	12%	13%	14%	16%	11%	13%	12%	11%
Other Income	2	6	10	10	5	6	11	13	10	35	42
Interest	34	34	27	31	30	24	13	13	22	22	18
Depreciation	45	45	47	49	51	62	74	71	83	100	108
Profit before tax	112	163	207	219	277	289	372	329	473	375	374
Tax %	40%	37%	29%	28%	31%	20%	19%	20%	19%	20%
Net Profit	67	103	148	158	191	230	302	263	381	301	307
EPS in Rs	19.03	28.97	41.64	44.57	53.87	64.99	85.22	74.12	107.46	85.03	86.45
Dividend Payout %	21%	31%	14%	16%	15%	22%	21%	24%	20%	26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	53.73%	43.69%	6.76%	20.89%	20.42%	31.30%	-12.91%	44.87%	-21.00%
Change in YoY Net Profit Growth (%)	0.00%	-10.04%	-36.93%	14.13%	-0.47%	10.89%	-44.22%	57.78%	-65.86%

Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	7%
3 Years:	11%
TTM:	4%

Compounded Profit Growth
10 Years:	%
5 Years:	10%
3 Years:	0%
TTM:	-3%

Stock Price CAGR
10 Years:	%
5 Years:	8%
3 Years:	-10%
1 Year:	-13%

Return on Equity
10 Years:	%
5 Years:	20%
3 Years:	18%
Last Year:	15%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 3:46 pm

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	35	35	35	35	35	35	35	35	35	35	35
Reserves	342	412	539	683	841	1,032	1,266	1,539	1,847	2,144	2,234
Borrowings	451	412	393	348	298	396	289	421	327	187	149
Other Liabilities	231	250	315	385	389	348	458	602	518	539	692
Total Liabilities	1,060	1,109	1,283	1,452	1,563	1,812	2,049	2,597	2,728	2,906	3,111
Fixed Assets	459	436	456	447	519	748	712	760	923	973	992
CWIP	7	51	10	25	83	66	124	205	139	158	215
Investments	0	0	0	0	0	6	43	0	0	198	254
Other Assets	594	623	817	980	962	992	1,170	1,630	1,665	1,576	1,650
Total Assets	1,060	1,109	1,283	1,452	1,563	1,812	2,049	2,597	2,728	2,906	3,111

Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹35.00 Cr..
For Reserves, as of Sep 2024, the value is ₹2,234.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,144.00 Cr. (Mar 2024) to ₹2,234.00 Cr., marking an increase of 90.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹149.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹187.00 Cr. (Mar 2024) to ₹149.00 Cr., marking a decrease of 38.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹692.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹539.00 Cr. (Mar 2024) to ₹692.00 Cr., marking an increase of 153.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹3,111.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,906.00 Cr. (Mar 2024) to ₹3,111.00 Cr., marking an increase of 205.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹992.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹973.00 Cr. (Mar 2024) to ₹992.00 Cr., marking an increase of 19.00 Cr..
For CWIP, as of Sep 2024, the value is ₹215.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹158.00 Cr. (Mar 2024) to ₹215.00 Cr., marking an increase of 57.00 Cr..
For Investments, as of Sep 2024, the value is ₹254.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹198.00 Cr. (Mar 2024) to ₹254.00 Cr., marking an increase of 56.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹1,650.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,576.00 Cr. (Mar 2024) to ₹1,650.00 Cr., marking an increase of 74.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹3,111.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,906.00 Cr. (Mar 2024) to ₹3,111.00 Cr., marking an increase of 205.00 Cr..

Notably, the Reserves (₹2,234.00 Cr.) exceed the Borrowings (149.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	41	170	111	145	283	316	365	5	573	518
Cash from Investing Activity +	-26	-59	-43	-54	-166	-149	-166	-82	-141	-341
Cash from Financing Activity +	-17	-110	-57	-90	-119	-144	-165	59	-264	-189
Net Cash Flow	-2	0	11	1	-2	23	34	-18	168	-11

Free Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-261.00	-176.00	-122.00	-60.00	55.00	-27.00	160.00	-20.00	241.00	275.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	43	51	59	63	56	62	62	63	50	57
Inventory Days	68	72	79	75	68	72	91	103	78	82
Days Payable	50	59	63	71	59	60	80	75	52	66
Cash Conversion Cycle	61	64	75	67	65	73	72	91	76	73
Working Capital Days	50	56	65	72	63	72	76	92	71	73
ROCE %		23%	26%	25%	28%	24%	25%	19%	24%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	70.93%	70.93%	70.93%	70.93%	70.93%	70.93%	70.93%	70.93%	70.93%	70.92%	70.91%	70.91%
FIIs	2.42%	2.05%	1.89%	2.01%	2.82%	2.78%	2.89%	2.99%	3.08%	3.61%	3.75%	3.87%
DIIs	13.29%	13.37%	13.78%	13.62%	12.73%	12.72%	12.66%	12.64%	12.56%	12.43%	12.73%	12.71%
Public	13.36%	13.65%	13.40%	13.44%	13.52%	13.59%	13.52%	13.43%	13.44%	13.03%	12.60%	12.51%
No. of Shareholders	60,512	64,375	62,531	62,895	63,034	64,787	64,037	63,858	63,396	59,611	58,029	56,328

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Balanced Advantage Fund	53,293,368	3.35	919.84	32,193,555	2025-03-11	65.54%
SBI Contra Fund	41,173,788	3.01	710.66	32,193,555	2025-03-11	27.89%
SBI Long Term Equity Fund	32,193,555	2.77	555.66	32,193,555	2025-03-11	0%
Quant ELSS Tax Saver Fund	21,120,000	5.04	364.53	32,193,555	2025-03-11	-34.4%
Franklin India Flexi Cap Fund	16,373,000	2	282.6	32,193,555	2025-03-11	-49.14%
DSP ELSS Tax Saver Fund	13,322,785	1.66	229.95	32,193,555	2025-03-11	-58.62%
SBI Arbitrage Opportunities Fund	10,961,700	0.71	189.2	32,193,555	2025-03-11	-65.95%
SBI Dividend Yield Fund	10,000,000	2.68	172.6	32,193,555	2025-03-11	-68.94%
DSP Equity Opportunities Fund	8,922,069	1.45	153.99	32,193,555	2025-03-11	-72.29%
Invesco India Arbitrage Fund	7,836,975	1.07	127.04	32,193,555	2025-03-11	-75.66%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	85.03	107.46	74.12	85.22	64.99
Diluted EPS (Rs.)	85.03	107.46	74.12	85.22	64.99
Cash EPS (Rs.)	113.20	131.02	94.17	106.09	82.54
Book Value[Excl.RevalReserv]/Share (Rs.)	614.74	531.04	444.10	367.11	301.20
Book Value[Incl.RevalReserv]/Share (Rs.)	614.74	531.04	444.10	367.11	301.20
Revenue From Operations / Share (Rs.)	1070.35	1253.95	1039.69	785.35	732.41
PBDIT / Share (Rs.)	140.39	163.08	116.56	129.67	105.73
PBIT / Share (Rs.)	112.23	139.53	96.52	108.81	88.19
PBT / Share (Rs.)	105.92	133.41	92.89	105.03	81.48
Net Profit / Share (Rs.)	85.04	107.47	74.13	85.23	65.00
NP After MI And SOA / Share (Rs.)	85.04	107.47	74.13	85.23	65.00
PBDIT Margin (%)	13.11	13.00	11.21	16.51	14.43
PBIT Margin (%)	10.48	11.12	9.28	13.85	12.04
PBT Margin (%)	9.89	10.63	8.93	13.37	11.12
Net Profit Margin (%)	7.94	8.57	7.12	10.85	8.87
NP After MI And SOA Margin (%)	7.94	8.57	7.12	10.85	8.87
Return on Networth / Equity (%)	13.83	20.23	16.69	23.21	21.57
Return on Capital Employeed (%)	17.21	24.07	19.71	26.98	25.15
Return On Assets (%)	10.34	13.93	10.10	14.74	12.71
Long Term Debt / Equity (X)	0.02	0.04	0.05	0.05	0.10
Total Debt / Equity (X)	0.06	0.14	0.23	0.18	0.29
Asset Turnover Ratio (%)	1.34	1.42	1.34	1.09	1.21
Current Ratio (X)	2.82	2.36	1.81	1.87	1.64
Quick Ratio (X)	1.90	1.41	0.99	1.18	1.07
Inventory Turnover Ratio (X)	4.15	4.30	4.78	4.19	4.22
Dividend Payout Ratio (NP) (%)	4.70	33.50	5.39	16.42	26.16
Dividend Payout Ratio (CP) (%)	3.53	27.48	4.24	13.19	20.60
Earning Retention Ratio (%)	95.30	66.50	94.61	83.58	73.84
Cash Earning Retention Ratio (%)	96.47	72.52	95.76	86.81	79.40
Interest Coverage Ratio (X)	22.22	26.64	32.16	34.25	15.75
Interest Coverage Ratio (Post Tax) (X)	14.46	18.56	21.45	23.51	10.68
Enterprise Value (Cr.)	7937.75	8295.42	10453.78	9184.23	4421.76
EV / Net Operating Revenue (X)	2.09	1.87	2.84	3.30	1.70
EV / EBITDA (X)	15.95	14.35	25.30	19.98	11.80
MarketCap / Net Operating Revenue (X)	2.12	1.86	2.76	3.25	1.60
Retention Ratios (%)	95.29	66.49	94.60	83.57	73.83
Price / BV (X)	3.69	4.39	6.45	6.96	3.89
Price / Net Operating Revenue (X)	2.12	1.86	2.76	3.25	1.60
EarningsYield	0.03	0.04	0.02	0.03	0.05

After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 85.03. This value is within the healthy range. It has decreased from 107.46 (Mar 23) to 85.03, marking a decrease of 22.43.
For Diluted EPS (Rs.), as of Mar 24, the value is 85.03. This value is within the healthy range. It has decreased from 107.46 (Mar 23) to 85.03, marking a decrease of 22.43.
For Cash EPS (Rs.), as of Mar 24, the value is 113.20. This value is within the healthy range. It has decreased from 131.02 (Mar 23) to 113.20, marking a decrease of 17.82.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 614.74. It has increased from 531.04 (Mar 23) to 614.74, marking an increase of 83.70.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 614.74. It has increased from 531.04 (Mar 23) to 614.74, marking an increase of 83.70.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,070.35. It has decreased from 1,253.95 (Mar 23) to 1,070.35, marking a decrease of 183.60.
For PBDIT / Share (Rs.), as of Mar 24, the value is 140.39. This value is within the healthy range. It has decreased from 163.08 (Mar 23) to 140.39, marking a decrease of 22.69.
For PBIT / Share (Rs.), as of Mar 24, the value is 112.23. This value is within the healthy range. It has decreased from 139.53 (Mar 23) to 112.23, marking a decrease of 27.30.
For PBT / Share (Rs.), as of Mar 24, the value is 105.92. This value is within the healthy range. It has decreased from 133.41 (Mar 23) to 105.92, marking a decrease of 27.49.
For Net Profit / Share (Rs.), as of Mar 24, the value is 85.04. This value is within the healthy range. It has decreased from 107.47 (Mar 23) to 85.04, marking a decrease of 22.43.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 85.04. This value is within the healthy range. It has decreased from 107.47 (Mar 23) to 85.04, marking a decrease of 22.43.
For PBDIT Margin (%), as of Mar 24, the value is 13.11. This value is within the healthy range. It has increased from 13.00 (Mar 23) to 13.11, marking an increase of 0.11.
For PBIT Margin (%), as of Mar 24, the value is 10.48. This value is within the healthy range. It has decreased from 11.12 (Mar 23) to 10.48, marking a decrease of 0.64.
For PBT Margin (%), as of Mar 24, the value is 9.89. This value is below the healthy minimum of 10. It has decreased from 10.63 (Mar 23) to 9.89, marking a decrease of 0.74.
For Net Profit Margin (%), as of Mar 24, the value is 7.94. This value is within the healthy range. It has decreased from 8.57 (Mar 23) to 7.94, marking a decrease of 0.63.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.94. This value is below the healthy minimum of 8. It has decreased from 8.57 (Mar 23) to 7.94, marking a decrease of 0.63.
For Return on Networth / Equity (%), as of Mar 24, the value is 13.83. This value is below the healthy minimum of 15. It has decreased from 20.23 (Mar 23) to 13.83, marking a decrease of 6.40.
For Return on Capital Employeed (%), as of Mar 24, the value is 17.21. This value is within the healthy range. It has decreased from 24.07 (Mar 23) to 17.21, marking a decrease of 6.86.
For Return On Assets (%), as of Mar 24, the value is 10.34. This value is within the healthy range. It has decreased from 13.93 (Mar 23) to 10.34, marking a decrease of 3.59.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 23) to 0.02, marking a decrease of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.06. This value is within the healthy range. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.34. It has decreased from 1.42 (Mar 23) to 1.34, marking a decrease of 0.08.
For Current Ratio (X), as of Mar 24, the value is 2.82. This value is within the healthy range. It has increased from 2.36 (Mar 23) to 2.82, marking an increase of 0.46.
For Quick Ratio (X), as of Mar 24, the value is 1.90. This value is within the healthy range. It has increased from 1.41 (Mar 23) to 1.90, marking an increase of 0.49.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.15. This value is within the healthy range. It has decreased from 4.30 (Mar 23) to 4.15, marking a decrease of 0.15.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.70. This value is below the healthy minimum of 20. It has decreased from 33.50 (Mar 23) to 4.70, marking a decrease of 28.80.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.53. This value is below the healthy minimum of 20. It has decreased from 27.48 (Mar 23) to 3.53, marking a decrease of 23.95.
For Earning Retention Ratio (%), as of Mar 24, the value is 95.30. This value exceeds the healthy maximum of 70. It has increased from 66.50 (Mar 23) to 95.30, marking an increase of 28.80.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.47. This value exceeds the healthy maximum of 70. It has increased from 72.52 (Mar 23) to 96.47, marking an increase of 23.95.
For Interest Coverage Ratio (X), as of Mar 24, the value is 22.22. This value is within the healthy range. It has decreased from 26.64 (Mar 23) to 22.22, marking a decrease of 4.42.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 14.46. This value is within the healthy range. It has decreased from 18.56 (Mar 23) to 14.46, marking a decrease of 4.10.
For Enterprise Value (Cr.), as of Mar 24, the value is 7,937.75. It has decreased from 8,295.42 (Mar 23) to 7,937.75, marking a decrease of 357.67.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.09. This value is within the healthy range. It has increased from 1.87 (Mar 23) to 2.09, marking an increase of 0.22.
For EV / EBITDA (X), as of Mar 24, the value is 15.95. This value exceeds the healthy maximum of 15. It has increased from 14.35 (Mar 23) to 15.95, marking an increase of 1.60.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.12. This value is within the healthy range. It has increased from 1.86 (Mar 23) to 2.12, marking an increase of 0.26.
For Retention Ratios (%), as of Mar 24, the value is 95.29. This value exceeds the healthy maximum of 70. It has increased from 66.49 (Mar 23) to 95.29, marking an increase of 28.80.
For Price / BV (X), as of Mar 24, the value is 3.69. This value exceeds the healthy maximum of 3. It has decreased from 4.39 (Mar 23) to 3.69, marking a decrease of 0.70.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.12. This value is within the healthy range. It has increased from 1.86 (Mar 23) to 2.12, marking an increase of 0.26.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Galaxy Surfactants Ltd as of March 12, 2025 is: ₹1,865.55

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Galaxy Surfactants Ltd is Overvalued by 10.74% compared to the current share price 2,090.00

Intrinsic Value of Galaxy Surfactants Ltd as of March 12, 2025 is: 1,870.90

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Galaxy Surfactants Ltd is Overvalued by 10.48% compared to the current share price 2,090.00

Last 5 Year EPS CAGR: 0.29%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 21.10%, which is a positive sign. The company has higher reserves (1,170.82 cr) compared to borrowings (333.73 cr), indicating strong financial stability. The company has shown consistent growth in sales (2.36 cr) and profit (290.00 cr) over the years.	The stock has a high average Working Capital Days of 69.00, which may not be favorable. The stock has a high average Cash Conversion Cycle of 71.70, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
1. Net Profit Margin: 7.94%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 17.21% (Industry Average ROCE: 10.49%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 13.83% (Industry Average ROE: 9.47%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 14.46
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.9
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 24.2 (Industry average Stock P/E: 79.64)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.06
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

GAIL (India) Ltd. is a Public Limited Listed company incorporated on 16/08/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L40200DL1984GOI018976 and registration number is 018976. Currently Company is involved in the business activities of Electric power generation, transmission and distribution. Company's Total Operating Revenue is Rs. 130573.05 Cr. and Equity Capital is Rs. 6575.10 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Gas Transmission/Marketing	16, Bhikaiji Cama Place, New Delhi Delhi 110066	shareholders@gail.co.in https://www.gailonline.com

Management
Name	Position Held
Mr. Sandeep Kumar Gupta	Chairman & Managing Director
Mr. Rakesh Kumar Jain	Director - Finance & CFO
Mr. Deepak Gupta	Director - Projects
Mr. Ayush Gupta	Director - Human Resources
Mr. Rajeev Kumar Singhal	Director - Business Development
Mr. Akhilesh Jain	Independent Director
Mr. Sher Singh	Independent Director
Mr. Sanjay Kashyap	Independent Director
Mr. Nandhagopal Narayanasamy	Independent Director
Mrs. Kangabam Inaocha Devi	Independent Director
Dr. Ravikant Kolhe	Independent Director
Mr. Sanjay Kumar	Director - Marketing
Mr. Praveen Mal Khanooja	Government Nominee Director
Mr. Kushagra Mittal	Government Nominee Director
Mr. Asheesh Joshi	Government Nominee Director

FAQ

What is the latest intrinsic value of Galaxy Surfactants Ltd?

The latest intrinsic value of Galaxy Surfactants Ltd as on 12 March 2025 is ₹1865.55, which is 10.74% lower than the current market price of ₹2,090.00, indicating the stock is overvalued by 10.74%. The intrinsic value of Galaxy Surfactants Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹7,421 Cr. and recorded a high/low of ₹3,370/2,072 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹2,234 Cr and total liabilities of ₹3,111 Cr.

What is the Market Cap of Galaxy Surfactants Ltd?

The Market Cap of Galaxy Surfactants Ltd is 7,421 Cr..

What is the current Stock Price of Galaxy Surfactants Ltd as on 12 March 2025?

The current stock price of Galaxy Surfactants Ltd as on 12 March 2025 is ₹2,090.

What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Galaxy Surfactants Ltd stocks is ₹3,370/2,072.

What is the Stock P/E of Galaxy Surfactants Ltd?

The Stock P/E of Galaxy Surfactants Ltd is 24.2.

What is the Book Value of Galaxy Surfactants Ltd?

The Book Value of Galaxy Surfactants Ltd is 640.

What is the Dividend Yield of Galaxy Surfactants Ltd?

The Dividend Yield of Galaxy Surfactants Ltd is 1.05 %.

What is the ROCE of Galaxy Surfactants Ltd?

The ROCE of Galaxy Surfactants Ltd is 17.4 %.

What is the ROE of Galaxy Surfactants Ltd?

The ROE of Galaxy Surfactants Ltd is 14.9 %.

What is the Face Value of Galaxy Surfactants Ltd?

The Face Value of Galaxy Surfactants Ltd is 10.0.